RTP startup backed by Eshelman hits clinical milestone
March 06, 2023 at 07:40 AM EST
A startup backed by one of North Carolina's most influential venture capitalists is moving its potential cancer treatment into a clinical study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
